Six Robotics Stocks For 2015
Debra Borchardt - at Seeking Alpha - Tue Feb 10, 2:32AM CST
FARO: 58.65 (-0.78), ISRG: 510.73 (+3.02), CGNX: 41.82 (+0.95), ARAY: 8.00 (+0.24), IRBT: 31.16 (+0.18), ROK: 117.90 (+1.02)
Accuray's TomoTherapy Gains Traction in Latin America (Revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:00AM CST
Accuray Inc's (ARAY) TomoTherapy System recently started operating breast cancer patients at Fundacion de Cancer de Mama (FUCAM) in Mexico City
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), ARAY: 8.00 (+0.24), LMNX: 15.45 (+0.02)
Accuray to Participate in the Cowen 35th Annual Healthcare Conference
PR Newswire - Mon Feb 09, 7:35AM CST
Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the Cowen 35th Annual Healthcare Conference in Boston on Monday, March 2, 2015 at 2:10pm ET. A live webcast of the presentation will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.
ARAY: 8.00 (+0.24)
Accuray's TomoTherapy Gains Traction in Latin America - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 5:25PM CST
Accuray Inc's (ARAY) TomoTherapy System recently started operating breast cancer patients at Fundacion de Cancer de Mama (FUCAM) in Mexico City.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02), ARAY: 8.00 (+0.24)
First TomoTherapy® System in Latin America Dedicated Solely to Breast Cancer Care Now Treating Patients
PR Newswire - Wed Feb 04, 7:00AM CST
Accuray Incorporated (Nasdaq: ARAY) announced today that the first TomoTherapy® System in Latin America dedicated solely to the treatment of breast cancer is now operational at FUCAM (Fundacion de Cancer de Mama) in Mexico City. More than 120 women have been treated with the innovative radiation therapy technology since the center began using it over two months ago. FUCAM's decision to install the TomoTherapy System reinforces growing medical community support for its use as a mainstream treatment to improve tumor control with reduced toxicities.
ARAY: 8.00 (+0.24)
Progress From Accuray, But Still No Big Turn
Stephen Simpson, CFA - at Seeking Alpha - Thu Jan 29, 8:50AM CST
VAR: 92.65 (+0.03), ARAY: 8.00 (+0.24)
Accuray (ARAY) Q2 Loss Wider than Expected, Revenues Lag - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 10:20AM CST
Radiation oncology company, Accuray Inc. (ARAY), reported a loss of 13 cents per share in the second quarter of fiscal 2015, wider than the Zacks Consensus Estimate of a loss of 8 cents and the year-ago loss of 7 cents per share.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), ARAY: 8.00 (+0.24), SURG: 4.44 (-0.02)
Accuray affirms guidance after FQ2 results
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 9:24AM CST
ARAY: 8.00 (+0.24)
Accuray's (ARAY) CEO Joshua Levine on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Jan 27, 9:07PM CST
ARAY: 8.00 (+0.24)
Accuray reports 2Q loss
Automated Insights - Tue Jan 27, 4:27PM CST
SUNNYVALE, Calif. (AP) _ Accuray Inc. (ARAY) on Tuesday reported a loss of $10 million in its fiscal second quarter.
ARAY: 8.00 (+0.24)
Accuray Incorporated (ARAY) Q2 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Jan 27, 3:25PM CST
ARAY: 8.00 (+0.24)
Accuray misses by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 3:10PM CST
ARAY: 8.00 (+0.24)
Accuray Reports Financial Results for Second Quarter of Fiscal Year 2015
PR Newswire - Tue Jan 27, 3:01PM CST
Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the second fiscal quarter and six months ended December 31, 2014.
ARAY: 8.00 (+0.24)
Accuray reports today
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 8:02AM CST
ARAY: 8.00 (+0.24)
Falling Earnings Estimates Signal Weakness Ahead for Accuray (ARAY) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 27, 7:32AM CST
Accuray has an unfavorable Zacks Rank and the stock has been witnessing a significant price decline and negative earnings estimate revisions
ARAY: 8.00 (+0.24), SURG: 4.44 (-0.02)
Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 4:35PM CST
VMW: 84.68 (+1.06), EA: 56.39 (+0.20), BXP: 141.08 (-1.58), AMCC: 5.21 (+0.06), ILMN: 198.54 (+1.81), ARAY: 8.00 (+0.24), MRCY: 17.42 (-0.17), JNPR: 23.84 (+0.19), YHOO: 44.42 (+0.50), T: 34.66 (+0.05), ACE: 113.05 (+0.09), CNMD: 48.98 (+1.80), FTK: 17.49 (+0.78), X: 26.36 (+1.12), AAPL: 127.08 (+0.62), SYK: 94.51 (+1.14), CLMS: 12.96 (-0.08), ETH: 27.00 (-0.24), OTEX: 61.19 (+0.99), AMGN: 153.48 (+0.30), CYT: 52.84 (+0.40), WDC: 107.61 (+0.42), POL: 40.05 (+0.20), TSS: 37.09 (+0.17), EZPW: 9.96 (-0.29), CNI: 70.04 (-0.39), DOX: 51.15 (+0.37), FSL: 37.53 (+2.83)
Will Accuray (ARAY) Disappoint Earnings Estimates in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 4:40PM CST
Accuray Inc. (ARAY) is set to report second-quarter 2015 results on Jan 27.
XENT: 23.06 (+0.46), ABBV: 58.05 (+1.00), ARAY: 8.00 (+0.24), HOLX: 30.46 (+0.21)
Accuray Has Returned 18.0% Since SmarTrend Recommendation (ARAY)
Comtex SmarTrend(R) - Thu Jan 22, 9:59AM CST
SmarTrend identified a Downtrend for Accuray (NASDAQ:ARAY) on July 18th, 2014 at $8.11. In approximately 6 months, Accuray has returned 17.95% as of today's recent price of $6.65.
ARAY: 8.00 (+0.24)
Health Care Equipment Equities Movers and Shakers - Boston Scientific, Medtronic, Zimmer Holdings, Accuray, and Second Sight Medical Products
PR Newswire - Thu Jan 22, 8:10AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Medtronic Inc. (NYSE: MDT), Zimmer Holdings Inc. (NYSE: ZMH), Accuray Inc. (NASDAQ: ARAY), and Second Sight Medical Products Inc. (NASDAQ: EYES). Free research report on Boston Scientific can be accessed at http://get.Investor-Edge.com/pdf/?c=Boston%20...&s=BSX. The US markets on Wednesday, January 21, 2015, ended on a positive note as the Dow Jones Industrial Average finished at 17,554.28, up 0.22% and the NASDAQ Composite closed at 4,667.42, up 0.27%. The S&P 500 finished the session 0.47% higher at 2,032.12. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 814.90, up 0.11%, with the index advancing 10.82% in the previous three months. Register for your complimentary reports at the links given below.
ZMH: 119.33 (+1.18), BSX: 14.98 (+0.24), EYES: 8.95 (-0.19), MDT: 75.26 (+0.33), ARAY: 8.00 (+0.24)
Earnings Preview: Intuitive Surgical Q4 2014
Selerity Research - at Seeking Alpha - Fri Jan 16, 12:49PM CST
ISRG: 510.73 (+3.02), RTIX: 5.54 (+0.19), MDT: 75.26 (+0.33), ARAY: 8.00 (+0.24), PVG: 6.44 (-0.07), DCTH: 1.14 (+0.04)